{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:34:58Z","timestamp":1780540498235,"version":"3.54.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2013-535"],"award-info":[{"award-number":["PICT 2013-535"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010677","name":"Instituto Nacional de Tecnolog\u00eda Agropecuaria","doi-asserted-by":"publisher","award":["PNBIO 1131032"],"award-info":[{"award-number":["PNBIO 1131032"]}],"id":[{"id":"10.13039\/501100010677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.molimm.2021.08.004","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T13:25:37Z","timestamp":1630502737000},"page":"115-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["MVA\u0394008 viral vector encoding the model protein OVA induces improved immune response against the heterologous antigen and equal levels of protection in a mice tumor model than the conventional MVA"],"prefix":"10.1016","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4164-8965","authenticated-orcid":false,"given":"Mar\u00eda Paula","family":"Del M\u00e9dico Zajac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Molinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Gravisaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2701-4109","authenticated-orcid":false,"given":"Daniel Omar","family":"Maizon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Mor\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Magdalena","family":"Gherardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3968-190X","authenticated-orcid":false,"given":"Gabriela","family":"Calamante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2021.08.004_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128626","article-title":"Deletion of fifteen open reading frames from modified vaccinia virus Ankara fails to improve immunogenicity","volume":"10","author":"Alharbi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2021.08.004_bib0010","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.3390\/v6072735","article-title":"Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory Diseases","volume":"6","author":"Altenburg","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.molimm.2021.08.004_bib0015","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/viro.1998.9123","article-title":"The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses","volume":"244","author":"Antoine","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.molimm.2021.08.004_bib0020","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.4049\/jimmunol.165.5.2651","article-title":"Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma","volume":"165","author":"Bellone","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2021.08.004_bib0025","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2017.1334746","article-title":"Modified Vaccinia virus Ankara-based vaccines in the era of personalized immunotherapy of cancer","author":"Bendjama","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"issue":"Pt 5","key":"10.1016\/j.molimm.2021.08.004_bib0030","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1099\/0022-1317-79-5-1159","article-title":"Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine","volume":"79","author":"Blanchard","year":"1998","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.molimm.2021.08.004_bib0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0378-1119(95)00149-Z","article-title":"Selection of recombinant vaccinia viruses on the basis of plaque formation","volume":"158","author":"Blasco","year":"1995","journal-title":"Gene"},{"key":"10.1016\/j.molimm.2021.08.004_bib0040","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.4049\/jimmunol.164.6.3246","article-title":"A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response","volume":"164","author":"Born","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2021.08.004_bib0045","doi-asserted-by":"crossref","first-page":"6508","DOI":"10.1016\/j.vaccine.2008.09.044","article-title":"Antigen delivery systems for veterinary vaccine development","volume":"26","author":"Brun","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2021.08.004_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2008.09.044","article-title":"Antigen delivery systems for veterinary vaccine development. Viral-vector based delivery systems","author":"Brun","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2021.08.004_bib0055","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0264-410X(96)00195-8","article-title":"Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor model","volume":"15","author":"Carroll","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2021.08.004_bib0060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1099\/vir.0.81417-0","article-title":"Detection of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy","volume":"87","author":"Clark","year":"2006","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.molimm.2021.08.004_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001638","article-title":"Recombination-mediated genetic Engineering of a bacterial artificial chromosome clone of Modified Vaccinia virus Ankara (MVA)","volume":"3","author":"Cottingham","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2021.08.004_bib0070","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1016\/j.vaccine.2008.06.011","article-title":"Pathogenicity and immunogenicity of recombinant Tiantan Vaccinia Virus with deleted C12L and A53R genes","volume":"26","author":"Dai","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2021.08.004_bib0075","doi-asserted-by":"crossref","DOI":"10.3791\/2250-v","article-title":"Antigen specific in vivo killing assay using CFSE labeled target cells","author":"Durward","year":"2010","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.molimm.2021.08.004_bib0080","series-title":"Current Protocols in Molecular Biology","article-title":"Preparation of cell cultures and vaccinia stocks","author":"Earl","year":"1998"},{"key":"10.1016\/j.molimm.2021.08.004_bib0085","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1189\/jlb.5RU0714-360RR","article-title":"Context-dependent role of IL-18 in cancer biology and counter-regulation by IL-18BP","volume":"97","author":"Fabbi","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.molimm.2021.08.004_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032220","article-title":"Improving the MVA vaccine potential by deleting the viral gene coding for the IL-18 binding protein","volume":"7","author":"Falivene","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2021.08.004_bib0095","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1158\/2326-6066.CIR-14-0050","article-title":"Intravenous injection of MVA virus targets CD8+ lymphocytes to tumors to control tumor growth upon combinatorial treatment with a TLR9 agonist","volume":"2","author":"Fend","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.molimm.2021.08.004_bib0100","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/vim.2011.0018","article-title":"Recombinant MVA expressing secreted glycoprotein D of BoHV-1 induces systemic and mucosal immunity in animal models","volume":"24","author":"Ferrer","year":"2011","journal-title":"Viral Immunol."},{"key":"10.1016\/j.molimm.2021.08.004_bib0105","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4161\/cbt.10.7.12926","article-title":"Dasatinib alters the metastatic phenotype of B16-OVA melanoma in vivo","volume":"10","author":"Fraser","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.molimm.2021.08.004_bib0110","doi-asserted-by":"crossref","first-page":"12605","DOI":"10.1128\/JVI.00246-12","article-title":"Deletion of specific immune-modulatory genes from modified vaccinia virus ankara-based HIV vaccines engenders improved immunogenicity in Rhesus macaques","volume":"86","author":"Garber","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.molimm.2021.08.004_bib0115","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1128\/JVI.02723-13","article-title":"Deletion of the vaccinia virus N2L gene encoding an inhibitor of IRF3 improves the immunogenicity of modified vaccinia virus ankara expressing HIV-1 antigens","volume":"88","author":"Garcia-Arriaza","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.molimm.2021.08.004_bib0120","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.4161\/hv.28974","article-title":"Enhancing poxvirus vectors vaccine immunogenicity","volume":"10","author":"Garc\u00eda-Arriaza","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.molimm.2021.08.004_bib0125","first-page":"5","article-title":"Immunogenic profiling in mice of a HIV\/AIDS vaccine candidate (MVA-B) expressing four HIV-1 antigens and potentiation by specific gene deletions","author":"Garc\u00eda-Arriaza","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2021.08.004_bib0130","first-page":"6","article-title":"A candidate HIV\/AIDS vaccine (MVA-B) lacking vaccinia virus gene C6L enhances memory HIV-1-specific T-cell responses","author":"Garc\u00eda-Arriaza","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2021.08.004_bib0135","first-page":"8","article-title":"Improving adaptive and memory immune responses of an HIV\/AIDS vaccine candidate MVA-B by deletion of vaccinia virus genes (C6L and K7R) blocking interferon signaling pathways","author":"Garc\u00eda-Arriaza","year":"2013","journal-title":"PLoS One"},{"issue":"247\u201366","key":"10.1016\/j.molimm.2021.08.004_bib0140","first-page":"517","article-title":"The complete DNA sequence of vaccinia virus","volume":"179","author":"Goebel","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.molimm.2021.08.004_bib0145","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2174\/156652311795684731","article-title":"MVA and NYVAC as vaccines against emergent infectious diseases and cancer","volume":"11","author":"G\u00f3mez","year":"2011","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.molimm.2021.08.004_bib0150","first-page":"8","article-title":"Deletion of A44L, A46R and C12L vaccinia virus genes from the MVA genome improved the vector immunogenicity by modifying the innate immune response generating enhanced and optimized specific T-cell responses","author":"Holgado","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.molimm.2021.08.004_bib0155","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1146\/annurev.immunol.14.1.207","article-title":"Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo","volume":"14","author":"K\u00e4gi","year":"1996","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molimm.2021.08.004_bib0160","first-page":"375","article-title":"The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism (author\u2019s transl)","volume":"167","author":"Mayr","year":"1978","journal-title":"Zentralbl Bakteriol B."},{"key":"10.1016\/j.molimm.2021.08.004_bib0165","first-page":"10","article-title":"Synergistic cancer immunotherapy combines MVA-CD40L induced innate and adaptive immunity with tumor targeting antibodies","author":"Medina-Echeverz","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molimm.2021.08.004_bib0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024108","article-title":"Baculovirus capsid display potentiates OVA cytotoxic and innate immune responses","volume":"6","author":"Molinari","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2021.08.004_bib0175","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1073\/pnas.96.6.2982","article-title":"Vaccination with a recombinant vaccinia virus encoding a self antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes","volume":"96","author":"Overwijk","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molimm.2021.08.004_bib0180","first-page":"7","article-title":"Deletion of the viral anti-apoptotic gene F1L in the HIV\/AIDS vaccine candidate MVA-C enhances immune responses against HIV-1 antigens","author":"Perdiguero","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2021.08.004_bib0185","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/vaccines8010070","article-title":"Deletion of vaccinia virus A40R gene improves the immunogenicity of the HIV-1 vaccine candidate MVA-B","volume":"8","author":"P\u00e9rez","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.molimm.2021.08.004_bib0190","doi-asserted-by":"crossref","first-page":"9960","DOI":"10.1128\/JVI.77.18.9960-9968.2003","article-title":"Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity","volume":"77","author":"Reading","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.molimm.2021.08.004_bib0195","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/21645515.2017.1373921","article-title":"Sequential administration of MVA-based vaccines and PD-1\/PD-L1-blocking antibodies confers measurable benefits on tumor growth and survival: preclinical studies with MVA-\u03b2Gal and MVA-MUC1 (TG4010) in a murine tumor model","volume":"14","author":"Remy-Ziller","year":"2018","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.molimm.2021.08.004_bib0200","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/jvi.60.2.436-449.1986","article-title":"Conserved TAAATG sequence at the transcriptional and translational initiation sites of vaccinia virus late genes deduced by structural and functional analysis of the HindIII H genome fragment","volume":"60","author":"Rosel","year":"1986","journal-title":"J. Virol."},{"key":"10.1016\/j.molimm.2021.08.004_bib0205","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.immunol.20.100201.131730","article-title":"Lymphocyte mediated cytotoxicity","volume":"20","author":"Russell","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molimm.2021.08.004_bib0210","first-page":"1223","article-title":"Ectromelia, vaccinia and cowpox viruses encode secreted interleukin-18-binding proteins","volume":"81","author":"Smith","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.molimm.2021.08.004_bib0215","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1099\/vir.0.80646-0","article-title":"Inactivation of the viral interleukin 1 receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara","volume":"86","author":"Staib","year":"2005","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.molimm.2021.08.004_bib0220","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1099\/0022-1317-83-11-2833","article-title":"The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model","volume":"83","author":"Symons","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.molimm.2021.08.004_bib0225","series-title":"Advances in Virus Research","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/bs.aivir.2016.07.001","article-title":"Modified vaccinia virus Ankara","author":"Volz","year":"2017"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016158902100242X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016158902100242X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:40:14Z","timestamp":1758980414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016158902100242X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":45,"alternative-id":["S016158902100242X"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2021.08.004","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MVA\u0394008 viral vector encoding the model protein OVA induces improved immune response against the heterologous antigen and equal levels of protection in a mice tumor model than the conventional MVA","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2021.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}